Fate Therapeutics, Inc. (FATE) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.28
Day's range
$1.38

Fate Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
REDMILE GROUP, LLC 05/15/2026 12.87 M $15.45 M   0.00% 10.84%
BLACKROCK, INC. 05/13/2026 10.07 M $12.08 M   -1.06% 8.48%
05/15/2026 4.19 M $5.03 M   100.00% 3.53%
05/08/2026 4.13 M $4.96 M   100.00% 3.48%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 4.12 M $4.94 M   40.53% 3.47%
TWO SIGMA INVESTMENTS, LP 05/15/2026 3.47 M $4.16 M   99.92% 2.92%
JOHNSON & JOHNSON 05/13/2026 3.38 M $4.05 M   0.00% 2.84%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 3.00 M $3.60 M   158.31% 2.53%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 2.97 M $3.57 M   26.00% 2.50%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.59 M $3.11 M   4.95% 2.18%
STATE STREET CORP 05/15/2026 2.26 M $2.72 M   -0.09% 1.91%
UBS GROUP AG 05/05/2026 1.82 M $2.19 M   351.45% 1.53%
GOLDMAN SACHS GROUP INC 05/15/2026 1.33 M $1.59 M   -7.48% 1.12%
TANG CAPITAL MANAGEMENT LLC 05/15/2026 1.17 M $1.40 M   0.00% 0.98%
CITADEL ADVISORS LLC 05/15/2026 942.93 K $1.13 M   25.83% 0.79%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 883.79 K $1.06 M   -43.97% 0.74%
IRENIC CAPITAL MANAGEMENT LP 05/18/2026 878.06 K $1.05 M   100.00% 0.74%
NORTHERN TRUST CORP 05/14/2026 811.92 K $974.31 K   10.82% 0.68%
MONACO ASSET MANAGEMENT SAM 05/11/2026 810.00 K $972.00 K   -2.41% 0.68%
BRUCE & CO., INC. 05/14/2026 789.19 K $947.03 K   8.23% 0.66%
MORGAN STANLEY 05/15/2026 767.75 K $921.30 K   -16.27% 0.65%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 756.27 K $907.53 K   -3.61% 0.64%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 653.76 K $784.51 K   100.00% 0.55%
JANE STREET GROUP, LLC 05/12/2026 646.98 K $776.38 K   -23.24% 0.54%
DAFNA CAPITAL MANAGEMENT LLC 05/15/2026 550.00 K $660.00 K   0.00% 0.46%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 469.79 K $563.74 K   322.37% 0.40%
MAN GROUP PLC 05/15/2026 430.07 K $516.09 K   64.67% 0.36%
PRIVIUM FUND MANAGEMENT B.V. 05/05/2026 414.31 K $497.17 K   12.25% 0.35%
XTX TOPCO LTD 05/15/2026 389.17 K $467.00 K   6.70% 0.33%
INVESCO LTD. 05/12/2026 375.89 K $451.06 K   -0.83% 0.32%
NUVEEN, LLC 04/30/2026 339.07 K $406.89 K   0.65% 0.29%
IEQ CAPITAL, LLC 05/15/2026 324.79 K $389.75 K   167.31% 0.27%
BANK OF NEW YORK MELLON CORP 05/05/2026 306.99 K $368.38 K   -0.20% 0.26%
GSA CAPITAL PARTNERS LLP 05/08/2026 298.88 K $359.00 K   39.90% 0.25%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 298.50 K $358.20 K   -3.77% 0.25%
WOODLINE PARTNERS LP 05/15/2026 238.65 K $286.38 K   -33.09% 0.20%
ASSENAGON ASSET MANAGEMENT S.A. 04/20/2026 190.25 K $228.30 K   27.98% 0.16%
BANK OF AMERICA CORP /DE/ 05/18/2026 188.56 K $226.28 K   24.79% 0.16%
ALLIANCEBERNSTEIN L.P. 05/15/2026 187.70 K $184.43 K   0.00% 0.16%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 185.00 K $222.00 K   37.04% 0.16%
LPL FINANCIAL LLC 05/06/2026 147.75 K $177.30 K   2.02% 0.12%
CWM, LLC 05/14/2026 139.80 K $167.76 K   169.93% 0.12%
SEI INVESTMENTS CO 05/13/2026 138.58 K $166.29 K   104.87% 0.12%
RHUMBLINE ADVISERS 05/12/2026 132.31 K $158.76 K   -9.85% 0.11%
HEADLANDS TECHNOLOGIES LLC 05/13/2026 125.71 K $150.85 K   100.00% 0.11%
05/15/2026 125.00 K $150.00 K   0.00% 0.11%
QUADRATURE CAPITAL LTD 05/15/2026 120.34 K $144.41 K   -59.63% 0.10%
CERITY PARTNERS LLC 05/15/2026 113.54 K $136.25 K   116.32% 0.10%
WELLS FARGO & COMPANY/MN 05/11/2026 100.98 K $121.17 K   -41.39% 0.09%
SCHULHOFF & CO INC 05/11/2026 100.00 K $120.00 K   100.00% 0.08%

Fate Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 229 institutional investors and hedge funds held shares of Fate Therapeutics Inc. The most heavily invested institutionals were:

Redmile Group, LLC: 12.87 M

BlackRock, Inc.: 10.07 M

ACADIAN ASSET MANAGEMENT LLC: 4.12 M

TWO SIGMA INVESTMENTS, LP: 3.47 M

JOHNSON & JOHNSON: 3.38 M

AQR CAPITAL MANAGEMENT LLC: 3 M

62.37% of Fate Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 100.26 M shares in the last 24 months. This purchase volume represents approximately $133.34 M in transactions.